Opioid flexion phenotype is a descriptive term for sustained forward flexion in fentanyl exposureOpioid Flexion Phenotype Helps Identify Potential Toxicity in Overdoses

The fentanyl era has produced recurrent community observations of people remaining upright or semi-upright in sustained forward flexion of the head and trunk with intermittent nodding, colloquially referred to as the “fentanyl nod” or “fentanyl fold.” Yet the motor state producing this appearance has never been measured directly. We conducted a structured narrative review spanning axial postural-control and reticulospinal neurophysiology, mu-opioid pharmacology, fentanyl-associated rigidity, alpha-2 adulterants, and observations from supervised consumption settings, and integrated these literatures into a testable framework. We introduce opioid flexion phenotype as a descriptive term for the observed configuration, deliberately holding it apart from any diagnostic or mechanistic claim. We advance disproportionate impairment of axial antigravity control as the primary hypothesis, set against three alternatives the evidence does not yet exclude: generalized sedation with loss of postural support; flexor-predominant rigidity or dystonia; and a mixed or fluctuating motor state. The hypothesis predicts that axial extensor activity will be reduced beyond that expected for the level of arousal at comparable ventilation, without increased flexor co-contraction or passive resistance. The rigidity literature prevents visual flexion from being equated with hypotonia, while alpha-2 agonists such as xylazine and medetomidine are better understood as state-dependent modifiers because they may deepen sedation, alter postural support or attenuate an established rigidity state. Persistent flexion after naloxone is non-specific and does not identify either co-exposure or motor mechanism. Discrimination among the accounts requires concurrent assessment of axial muscle activity, passive tone, arousal, ventilation, kinematics, toxicological exposure and longitudinal response. The immediate clinical and harm reduction implications are mechanism-independent: forward flexion should prompt assessment for toxicity rather than dismissal as sleep or voluntary posture; ventilation, not posture, governs urgency and naloxone titration in suspected opioid overdose; and neither appearance nor naloxone response identifies the underlying motor state. The flexed presentation has been read confidently as sedation, hypotonia and rigidity; none of these interpretations is yet warranted, and the instruments needed to adjudicate among them exist, while the observational protocol does not.